<DOC>
	<DOCNO>NCT03065465</DOCNO>
	<brief_summary>The primary specific aim perform randomize control trial ( RCT ) compare rebleeding rate clinical outcome severe , refractory recurrent non-variceal upper GI hemorrhage ( NVUGIH ) new over-the-scope hemoclipping device ( OVESCO ) versus standard endoscopic hemostasis .</brief_summary>
	<brief_title>Standard Endoscopic Hemostasis Versus OVESCO Severe Non-variceal UGI Hemorrhage</brief_title>
	<detailed_description>Upper GI Hemorrhage ( UGIH ) cause significant morbidity mortality , although endoscopic hemostasis revolutionize management patient . Despite standard endoscopic treatment high dose proton pump infusion , 27 % patient referral hospital upper gastrointestinal bleeding ( UGIB ) ulcers non-variceal UGI lesion ( NVUGI ) refractory recurrent bleed recent RCT group . Potential risk factor NVUGI bleed lesion large ulcer ( ≥ 15 mm ) , fibrotic base , Dieulafoy 's lesion , anastomotic ulcer , coagulopathies , cirrhosis , severe co-morbidities , residual arterial blood flow stigmata endoscopic hemostasis . Such patient severe rebleeding standard endoscopic hemostasis usually require angiography ( interventional radiologists-IR ) surgery definitive hemostasis . A new , large , FDA approve , over-the-scope hemoclipping device ( OTSC® System OVESCO Endoscopy , Tübingen , Germany ) capture large amount tissue large underlie artery standard hemoclips potentially could improve endoscopic hemostasis bleeding lesion .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>Written inform consent patient surrogate . Clinical evidence severe UGIB . Presence benign appear peptic ulcer , postEndoscopic mucosal resection ( EMR ) ulcer , anastomotic ulcer , Dieulafoy 's lesion , UGI postpolypectomy induce ulcer SRH endoscopy . Severe bleeding , refractory bleeding , recurrent bleeding . Life expectancy least 30 day base lack severe terminal comorbidity judge generalist subspecialist care patient . Patients donotresuscitate ( DNR ) reversible , uncooperative , refuse participate , unable give consent personally surrogate . Active GI malignancy , treatment remission . Acute hypovolemic shock unresponsive transfusion 5 unit red blood cell ( RBC 's ) require continuous intravenous vasopressor infusion blood pressure support . ASA ( American Society Anesthesiology ) class V , moribund , poor prognosis expect survival &lt; 30 day . Severe coagulopathy thrombocytopenia despite attempted reversal transfusion blood product ( e.g persistent International Normalized Ratio [ INR ] &gt; 2.0 , platelet count &lt; 20,000 , Partial Thromboplastin Time [ PTT ] great 2x upper limit normal ) . Absolute contraindication urgent endoscopy ( suspect perforate viscus , peritonitis , unstable cardiopulmonary status ) . Stricture esophagus pylorus dilate precludes passage 12 mm diameter endoscope and/or GI endoscope large hemoclipping deviceOvesco .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Upper GI hemorrhage</keyword>
	<keyword>Stigmata recent hemorrhage</keyword>
	<keyword>Diverticular Hemorrhage</keyword>
	<keyword>Ulcers</keyword>
</DOC>